Panacea Bio share price surges 6% after completing enrollment of study participants for Dengiall Phase-III trial by Live mint | January 8, 2026 1:06 pm | Indian Stocks, Market, News Panacea Bio share price has gained 7.27% in the past five sessions and nearly 21% in a month. However, the scrip has declined by over 11% a year.
